Tecan appoints Dr David Martyr new Chief Executive Officer
(Thomson Reuters ONE) -
Tecan Group AG /
Tecan appoints Dr David Martyr new Chief Executive Officer
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Männedorf, Switzerland, February 13, 2012 - The Tecan Group (SIX Swiss Exchange:
TECN) today announced that the Board of Directors has appointed Dr David Martyr
as Chief Executive Officer of the Company. He will join the company as soon as
his current contractual obligations permit, but no later than October 8, 2012.
As announced on October 7, 2011, the Board of Directors had initiated a
succession process for the top management position. Thomas Bachmann, CEO of the
Group since the beginning of 2005, will leave Tecan effective immediately. The
Board of Directors has appointed Gérard Vaillant as acting Chief Executive
Officer until David Martyr joins the company. Gérard Vaillant has been a member
of the Tecan Board of Directors since 2004.
David Martyr joins Tecan with an extensive management career in technology
businesses, including 13 years of leadership experience in the life sciences
sector and analytical instrument industry. Most recently, David Martyr was Group
President of Leica Microsystems since 2007 and concurrently Vice President at
Danaher Corporation, with responsibility for Danaher's Life Science businesses
since 2009. During the period 2007 to 2011 at Leica Microsystems, the company's
business grew from around USD 500 million annual sales to over USD 1.2 billion,
through driving organic growth, the introduction of reagents and consumables to
complement its instruments, significantly expanding sales in China; and through
the acquisition and integration of several companies.
"David Martyr has extensive leadership experience in the life sciences industry
and a successful track record in improving the performance of his businesses as
well as growing new business opportunities," said Rolf Classon, Chairman of
Tecan's Board of Directors. "David has extensive knowledge and experience in
sales, marketing and business development within the life sciences sector and we
are convinced that under his leadership Tecan will continue to generate
accelerated profitable growth."
"Tecan is the premier brand in laboratory automation and I am excited to join
the Company at a time when automation is gaining widespread adoption in the Life
Sciences and Clinical Diagnostics," said David Martyr. "Together with the
management team, I look forward to continue to implement Tecan's successful
growth strategy in both the Life Sciences Business and the Partnering Business
segments and to further build value for our shareholders."
Rolf Classon continued: "During the tenure of Thomas Bachmann, Tecan has
improved operational effectiveness, improved earnings per share and built a
strong balance sheet. We will continue to build on this solid foundation and
will ensure continuity, also under the new leadership. The Board thanks Thomas
Bachmann for his important accomplishments and strong commitment and we wish him
the very best going forward."
Additional information on David Martyr
David Martyr joined Leica Microsystems in 1998 and was appointed President of
Leica Microsystems Group in January 2007 with full responsibility for Leica
Microsystems, Leica Biosystems and Invetech.
Leica Microsystems Group, with over 4000 employees in 20 countries, is a leading
player in Life Science instrumentation, Microscopy, Cancer Diagnostics
(instruments and reagents), Medical Technologies and advanced imaging systems
for industrial and forensic applications.
Since January 2009 David Martyr concurrently served as Group Executive and Vice
President of Danaher Corporation (NYSE: DHR), the shareholder of Leica
Microsystems Group. In this role he was responsible for overseeing the
development of Danaher's Life Science businesses, which today also include mass
spectrometry company AB Sciex and Molecular Devices focused on detection
instruments.
Prior to being appointed as President, David Martyr held various management and
professional positions at Leica Microsystems, including Executive Vice President
Worldwide Sales and Marketing and Managing Director, Europe.
Prior to joining Leica Microsystems David Martyr worked for laser technology
companies Lumonics Inc. and Ferranti plc in a variety of management and sales-
related positions.
David Martyr holds a B.Sc. in Naval Architecture and earned a doctorate in
Engineering at the University of Newcastle-upon-Tyne, United Kingdom. He is 54
years old and a British citizen.
A photo of Dr David Martyr can be requested at investor(at)tecan.com
About Tecan
Tecan (www.tecan.com) is a leading global provider of laboratory instruments and
solutions in biopharmaceuticals, forensics and clinical diagnostics. The company
specializes in the development, production and distribution of automated
workflow solutions for laboratories in the life sciences sector. Its clients
include pharmaceutical and biotechnology companies, university research
departments, forensic and diagnostic laboratories. As an original equipment
manufacturer (OEM), Tecan is also a leader in developing and manufacturing OEM
instruments and components that are then distributed by partner companies.
Founded in Switzerland in 1980, the company has manufacturing, research and
development sites in both Europe and North America and maintains a sales and
service network in 52 countries. In 2010, Tecan generated sales of
CHF 371 million (USD 356 million; EUR 269 million). Registered shares of Tecan
Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN:
1210019).
For further information:
Tecan Group
Martin Braendle
Head of Corporate Communications & Investor Relations
Tel. +41 (0) 44 922 84 30
Fax +41 (0) 44 922 88 89
investor(at)tecan.com
www.tecan.com
Press Release (PDF):
http://hugin.info/100384/R/1584853/495947.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Tecan Group AG via Thomson Reuters ONE
[HUG#1584853]
Unternehmensinformation / Kurzprofil:
Datum: 13.02.2012 - 07:15 Uhr
Sprache: Deutsch
News-ID 113582
Anzahl Zeichen: 7106
contact information:
Town:
Männedorf
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 306 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Tecan appoints Dr David Martyr new Chief Executive Officer"
steht unter der journalistisch-redaktionellen Verantwortung von
Tecan Group AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
